Investment
Features
FeesSafety
Academy
More
Pluang+

3E Network secures 9 MVA power deal for Finnish AI compute center, boosting green AI infrastructure plans.

Market News
19 Oct 2026
GlobeNewsWire
View Source
Bullish
3E Network secures 9 MVA power deal for Finnish AI compute center, boosting green AI infrastructure plans.

3E Network Technology Group's Finnish subsidiary, Aurora Core Technology Oy, signed a 9 MVA power distribution agreement with Järvi-Suomen Energia Oy to support its Mikkeli AI compute center. This deal ensures the stable, high-capacity power needed for advanced AI servers and cooling systems, aligning with their 2027 operational launch plans. The project leverages Finland's clean energy grid, enhancing the company's green AI services and competitive edge in the European market. Next steps include infrastructure engineering and equipment procurement to meet the scheduled commercial operation in 2027.

3E Network's power distribution agreement for the Mikkeli AI compute center is the subject, with Pluang's Technology sector market data as context. As of Oct 19, 2026 18:31 WIB, out of 150 priced Technology-sector US stocks tradable on Pluang, 101 rose and 36 fell. Notable movers include ASX at USD 41.18 with a +4.17% change and a typical hold time of 49 days, LRCX at USD 274.91 with a +4.16% change and a 61-day hold time, and IREN at USD 28.11 with a +4.15% change and a 29-day hold time.

More News

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics to host event on clinical measures in PKP2 arrhythmogenic cardiomyopathy

Lexeo Therapeutics announced an educational event on October 21, 2026, focusing on clinical endpoints and outcome measures in PKP2 arrhythmogenic cardiomyopathy (PKP2-ACM). The event will feature discussions by Lexeo's Chief Medical Officer and a lea...

Others
Neutral
1 hour ago
EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint's DURAVYU misses primary endpoint in wet AMD trial but shows reduced treatment burden and safety.

EyePoint announced that its DURAVYU treatment for wet age-related macular degeneration (wet AMD) did not meet the primary goal of matching the visual improvement of the standard aflibercept treatment in the LUCIA Phase 3 trial. However, DURAVYU demon...

Company Fundamentals
Neutral
1 hour ago
Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics wins $2.6M FDA grant to advance MT-601 therapy for pancreatic cancer.

Marker Therapeutics has been awarded a $2.6 million grant from the FDA's Orphan Products Clinical Trials program to support a Phase 1 study of its MT-601 multi-antigen recognizing T cell therapy for locally advanced unresectable pancreatic cancer. Th...

Market News
Bullish
1 hour ago
Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics appoints Mark Vale as audit committee chair ahead of public listing.

Agility Robotics announced that Mark Vale, former UPS president and current CEO of Transportation Insight, will join its board and chair the audit committee after its merger with Churchill Capital Corp XI. Vale's extensive experience in global logist...

Company Fundamentals
Bullish
1 hour ago
JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash wins Silver Award for innovation in InsurTech at Money20/20 USA 2026

JazzCash, Pakistan's leading digital financial services platform, won the Silver Award in the Banking – InsurTech category at Money20/20 USA 2026 for its health-protection platform Sehat+. This platform provides affordable health insurance to Pakista...

Market News
Bullish
1 hour ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App